Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 3
Results: 13
Herpes zoster prophylaxis with low‐dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 298, doi. 10.1111/ejh.13810
- By:
- Publication type:
- Article
Relationship between pancreatic iron overload, glucose metabolism and cardiac complications in sickle cell disease: An Italian multicentre study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 289, doi. 10.1111/ejh.13809
- By:
- Publication type:
- Article
Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 305, doi. 10.1111/ejh.13808
- By:
- Publication type:
- Article
Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 282, doi. 10.1111/ejh.13807
- By:
- Publication type:
- Article
Cell‐free DNA levels are increased in acute graft‐versus‐host disease.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 271, doi. 10.1111/ejh.13806
- By:
- Publication type:
- Article
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 257, doi. 10.1111/ejh.13805
- By:
- Publication type:
- Article
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 250, doi. 10.1111/ejh.13804
- By:
- Publication type:
- Article
Incidence of adult primary immune thrombocytopenia in England—An update.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 238, doi. 10.1111/ejh.13803
- By:
- Publication type:
- Article
Validation of patient‐reported vaso‐occlusive crisis day as an endpoint in sickle cell disease studies.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 226, doi. 10.1111/ejh.13790
- By:
- Publication type:
- Article
Development and validation of the sickle cell stress scale‐adult.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 215, doi. 10.1111/ejh.13789
- By:
- Publication type:
- Article
Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 205, doi. 10.1111/ejh.13783
- By:
- Publication type:
- Article
Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real‐world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 197, doi. 10.1111/ejh.13773
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 195, doi. 10.1111/ejh.13659
- Publication type:
- Article